Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Naltrexone and Varenicline for Alcohol Use Disorder
NCT04249882Phase 2Completed
- Sponsor
- University of California, Los Angeles
- Start
- Jan 2020
- Primary completion
- Jun 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of naltrexone, varenicline in alcohol use disorder (AUD), sponsored by University of California, Los Angeles. Started Jan 2020; status: completed.
02
Drugs
naltrexonevarenicline
03
Conditions
alcohol use disorder (AUD)
Beyond the preview
Go deeper on NCT04249882.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04249882.